Approval · Notice of Compliance 3804 · 1997
FLAVOXATE: Notice of Compliance 3804
Issued December 3, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3804
- Date
- December 3, 1997
- Company
- Pharmel Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Urinary tract antispasmodic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLAVOXATE | 02236956 | Cancelled Post Market |
Medicinal ingredients
- FLAVOXATE HCL 200 MG per TAB